A
AtriCure
About AtriCure
AtriCure, Inc. is a medical device company that develops, manufactures and sells surgical devices for the treatment of atrial fibrillation (Afib) and related conditions, used by electrophysiologists and cardiothoracic surgeons. Its product areas include surgical ablation systems, the AtriClip left atrial appendage exclusion (management) system, Hybrid AF Convergent therapy, and cryo nerve block devices for post-operative pain management. AtriCure is a publicly traded company (Nasdaq: ATRC).
Industry
Medical devices (cardiac surgery / atrial fibrillation treatment)
Headquarters
Mason, Ohio, USA (7555 Innovation Way, Mason, OH 45040)
Company size
Approximately 750 employees (2021)
Founded
2000
What we do
Surgical ablation devices for atrial fibrillationLeft atrial appendage management (AtriClip exclusion system)Hybrid AF (Convergent) therapyCryo nerve block for post-operative pain managementMinimally invasive surgical instruments for cardiac procedures
Interested in AtriCure?
Join our talent pool to be considered for future opportunities.
